Amiodarone-Induced Thyrotoxicosis Is a Predictor of Adverse Cardiovascular Outcome | Zendy

KaiHang Yiu | Zendy; ManHong Jim | Zendy; ChungWah Siu | Zendy; ChiHo Lee | Zendy; Michele Yuen | Zendy; Maggie Ming Yee Mok | Zendy; Yet-Fung Shea | Zendy; Katherine Fan | Zendy; HungFat Tse | Zendy; WingHing Chow | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Amiodarone-Induced Thyrotoxicosis Is a Predictor of Adverse Cardiovascular Outcome

Author(s) -

KaiHang Yiu,

ManHong Jim,

ChungWah Siu,

ChiHo Lee,

Michele Yuen,

Maggie Ming Yee Mok,

Yet-Fung Shea,

Katherine Fan,

HungFat Tse,

WingHing Chow

Publication year - 2008

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2008-1907

Subject(s) - mace , medicine , amiodarone , hazard ratio , euthyroid , cardiology , ejection fraction , confidence interval , myocardial infarction , heart failure , adverse effect , proportional hazards model , atrial fibrillation , thyroid , percutaneous coronary intervention

Amiodarone-induced thyrotoxicosis (AIT) is a clinical condition that is notoriously difficult to manage; the relative risk of adverse cardiovascular events in these patients compared with euthyroid patients is largely unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research